SCHEMBL4510688

SCHEMBL4510688

CC(C)(N)Cc1c[nH]c2ccc(Cl)cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 2/20 0.63
▸ HTR2A P28223 4/20 0.60
▸ TRPM8 Q7Z2W7 1/20 0.60
▸ SLC6A4 P31645 3/20 0.54
▸ IDO1 P14902 1/20 0.50
▸ MTNR1A P48039 1/20 0.50
▸ MTNR1B P49286 1/20 0.50
▸ GFER P55789 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ TSHR P16473 1/20 0.47
▸ ADRA1D P25100 2/20 0.47
▸ ADRA1A P35348 2/20 0.47
▸ ADRA1B P35368 2/20 0.47
▸ HTR1D P28221 2/20 0.47
▸ HTR1A P08908 1/20 0.47
▸ ADRA2A P08913 1/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ ADRA2B P18089 1/20 0.47
▸ ADRA2C P18825 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505527 0.88 GPR84 (0.63) GPR84HTR2ATRPM8SLC6A4IDO1
SCHEMBL12396967 0.87 GPR84 (0.67) GPR84HTR2ATRPM8SLC6A4IDO1
SCHEMBL11819055 0.87 GPR84 (0.58) GPR84HTR2ATRPM8SLC6A4IDO1
SCHEMBL22879502 0.84 GPR84 (0.63) GPR84HTR2ATRPM8SLC6A4IDO1
SCHEMBL27659097 0.84 HPGD (0.54) HTR2ATRPM8TSHRHTR1DHTR1A
SCHEMBL9531949 0.83 HTR2A (0.68) GPR84HTR2ATRPM8SLC6A4IDO1
Hydrochloric Acid SCHEMBL27549572 0.83 HPGD (0.52) HTR2ATRPM8TSHRHTR1DHTR1A
Hydrochloric Acid SCHEMBL10491428 0.82 HTR2A (0.66) GPR84HTR2ATRPM8SLC6A4IDO1
SCHEMBL9772865 0.81 HTR2C (0.60) HTR2ASLC6A4IDO1HSD17B10TSHR
SCHEMBL14527163 0.81 MPO (0.64) GPR84HTR2ATRPM8SLC6A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612099-B2 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-03 — — US disclosed
CN-101321749-A Novel vinylogous acid derivatives HOFFMANN LA ROCHE (CH) 2008-12-10 — — CN disclosed
EP-1957483-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-08-20 — — EP disclosed
WO-2007063010-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 — — WO disclosed
US-20070129421-A1 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. 2007-06-07 — — US disclosed
US-5436264-A Adrenergic blocking agents for vasoconstriction and hypotensive agents SYNTEX (U.S.A.) INC. (US) 1995-07-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129421-A1 Vinylogous acid derivatives CMA1, TPSG1, TPSAB1 GPR84 476/4885HTR2A 2869/4885TRPM8 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback